Cambridge Investment Research Advisors’s AllianzIM 6 Month Buffer10 Allocation ETF SPBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.57M Sell
169,589
-27,704
-14% -$763K 0.01% 1017
2025
Q4
$5.42M Buy
197,293
+41,834
+27% +$1.13M 0.01% 887
2025
Q3
$4.18M Buy
155,459
+60,148
+63% +$1.59M 0.01% 1015
2025
Q2
$2.47M Buy
+95,311
New +$2.36M 0.01% 1268

Other funds holding SPBX

Cambridge Investment Research Advisors's SPBX Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its AllianzIM 6 Month Buffer10 Allocation ETF (SPBX) stake by 14% in Q1 2026, selling an estimated $763K and leaving 169,589 shares worth $4.57M. The position accounts for 0.01% of the portfolio, ranked #1017.

Cambridge Investment Research Advisors first reported a position in SPBX in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.42M in Q4 2025. 21 funds tracked by Wall St. Rank hold SPBX as of Q1 2026.

  • Cambridge Investment Research Advisors held 169,589 shares of AllianzIM 6 Month Buffer10 Allocation ETF worth $4.57M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 27,704 AllianzIM 6 Month Buffer10 Allocation ETF shares in Q1 2026, an estimated $763K.
  • AllianzIM 6 Month Buffer10 Allocation ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1017 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM 6 Month Buffer10 Allocation ETF in Q2 2025 and has held it in 4 quarters since.
  • Cambridge Investment Research Advisors's AllianzIM 6 Month Buffer10 Allocation ETF position peaked at $5.42M in Q4 2025.
  • 21 funds tracked by Wall St. Rank held AllianzIM 6 Month Buffer10 Allocation ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.